Cellular Origins is focused on enabling scalable, cost-effective and space efficient manufacture of cell and gene therapies.
As a TTP Company, the expertise within Cellular Origins builds on more than 30 year’s experience in supporting the world’s most innovative and ambitious companies develop new tools and technologies.
“Cell therapies have shown the ability to cure the incurable, and yet we cannot get them to patients because of an inability to scale manufacturing. At Cellular Origins, we want therapy developers to be able to scale the processes they have tried, tested and proven. And then in the future, as further technologies emerge that further enhance the efficacy of these therapies, we want to ensure that these too can be manufactured for patients everywhere.”
Dr Edwin Stone | CEO | Cellular Origins
As featured in:
Sign up for updates.
Stay up-to-date with Cellular Origins and our modular factory automation for cell and gene therapies.